Quantrx Biomedical (QTXB) 0.0360 $QTXB QuantRx(
Post# of 273239
Posted On: 04/12/2015 8:27:21 AM
Quantrx Biomedical (QTXB) 0.0360 $QTXB
QuantRx(R) Biomedical Provides Update on Point of Care Diagnostics Division
Marketwired - Thu Mar 19, 7:01AM CDT
QuantRx(R) Biomedical Corporation (OTCBB: QTXB) is pleased to announce that it is actively seeking strategic partners for its Point of Care ("POC"
diagnostics division, which is focused on the commercialization of innovative lateral flow diagnostic products that utilize the Company's patented exceptionally sensitive and quantitative fluorescent lateral flow technology platforms.
QuantRx(R) Biomedical Provides Update on Technological Progress of Its Genomic Diagnostics Platforms
Marketwired - Tue Mar 03, 7:00AM CST
QuantRx(R) Biomedical Corporation ("QuantRx" or the "Company" (OTCBB: QTXB), an emerging provider of innovative healthcare solutions for feminine care, laboratory based point-of-care diagnostics, and genomic testing, all of which leverage its robust portfolio of patented intellectual property, is pleased to announce continued progress and exciting development across its business lines.
QuantRx(R) Biomedical Provides Update on Point of Care Diagnostics Division
Marketwired - Thu Mar 19, 7:01AM CDT
QuantRx(R) Biomedical Corporation (OTCBB: QTXB) is pleased to announce that it is actively seeking strategic partners for its Point of Care ("POC"
diagnostics division, which is focused on the commercialization of innovative lateral flow diagnostic products that utilize the Company's patented exceptionally sensitive and quantitative fluorescent lateral flow technology platforms. QuantRx(R) Biomedical Provides Update on Technological Progress of Its Genomic Diagnostics Platforms
Marketwired - Tue Mar 03, 7:00AM CST
QuantRx(R) Biomedical Corporation ("QuantRx" or the "Company"
(OTCBB: QTXB), an emerging provider of innovative healthcare solutions for feminine care, laboratory based point-of-care diagnostics, and genomic testing, all of which leverage its robust portfolio of patented intellectual property, is pleased to announce continued progress and exciting development across its business lines. 
(0)
(0)